Contract facts
FederalRADIOPHARMACEUTICALS: LUTETIUM LU 177 PLUVICTO 27MCI/ML. OY1. is a federal award for 260-Network Contract Office 20 (36C260) held by Advanced Accelerator Applications Usa, Inc. Estimated value —. Related solicitation NONE.
RADIOPHARMACEUTICALS: LUTETIUM LU 177 PLUVICTO 27MCI/ML. OY1.
Incumbent footprint
Public recordAdvanced Accelerator Applications Usa, Inc — $43.0M obligated across 114 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C26025A0008?
36C26025A0008 (Radiopharmaceuticals: lutetium LU 177 pluvicto) is a 260-Network Contract Office 20 (36C260) award with an estimated value of —, currently held by Advanced Accelerator Applications Usa, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C260-25-A-0008?
36C260-25-A-0008 is the dashed form of PIID 36C26025A0008 (Radiopharmaceuticals: lutetium LU 177 pluvicto), held by Advanced Accelerator Applications Usa, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C26025A0008?
260-Network Contract Office 20 (36C260) awarded 36C26025A0008 to Advanced Accelerator Applications Usa, Inc.
Who is the incumbent on 36C26025A0008?
Advanced Accelerator Applications Usa, Inc is the incumbent with $43.0M across 114 related awards in SCOUT’s public footprint.
When does Advanced Accelerator Applications Usa, Inc’s 36C26025A0008 come up for recompete?
SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.